Miller BL - Search Results

1

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.

Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL. Tsai RM, et al. Among authors: miller z, miller bl. JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812. JAMA Neurol. 2020. PMID: 31710340 Free PMC article. Clinical Trial.

2

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, et al. Motter R, et al. Ann Neurol. 1995 Oct;38(4):643-8. doi: 10.1002/ana.410380413. Ann Neurol. 1995. PMID: 7574461

3

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

Vigo-Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I, et al. Vigo-Pelfrey C, et al. Neurology. 1995 Apr;45(4):788-93. doi: 10.1212/wnl.45.4.788. Neurology. 1995. PMID: 7723971

4

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease.

Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P. Galasko D, et al. Neurology. 1997 Mar;48(3):632-5. doi: 10.1212/wnl.48.3.632. Neurology. 1997. PMID: 9065538 Clinical Trial.

5

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

6

Frontotemporal dementia.

Rosen HJ, Lengenfelder J, Miller B. Rosen HJ, et al. Neurol Clin. 2000 Nov;18(4):979-92. doi: 10.1016/s0733-8619(05)70235-8. Neurol Clin. 2000. PMID: 11072270 Review.

7

Patterns of cerebral atrophy in primary progressive aphasia.

Rosen HJ, Kramer JH, Gorno-Tempini ML, Schuff N, Weiner M, Miller BL. Rosen HJ, et al. Among authors: miller bl. Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):89-97. Am J Geriatr Psychiatry. 2002. PMID: 11790639

8

Emotion comprehension in the temporal variant of frontotemporal dementia.

Rosen HJ, Perry RJ, Murphy J, Kramer JH, Mychack P, Schuff N, Weiner M, Levenson RW, Miller BL. Rosen HJ, et al. Among authors: miller bl. Brain. 2002 Oct;125(Pt 10):2286-95. doi: 10.1093/brain/awf225. Brain. 2002. PMID: 12244085

9

Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia.

Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ. Boxer AL, et al. Among authors: miller bl. Arch Neurol. 2003 Jul;60(7):949-56. doi: 10.1001/archneur.60.7.949. Arch Neurol. 2003. PMID: 12873851

10

Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.

Kramer JH, Jurik J, Sha SJ, Rankin KP, Rosen HJ, Johnson JK, Miller BL. Kramer JH, et al. Among authors: miller bl. Cogn Behav Neurol. 2003 Dec;16(4):211-8. doi: 10.1097/00146965-200312000-00002. Cogn Behav Neurol. 2003. PMID: 14665820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,547 results

Search Page